drugset / Trial / NCT03458468

Tranexamic Acid for the Latarjet Procedure.

NCT03458468 ↗

Completed 100 enrolled Sports Surgery Clinic, Santry, Dublin
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The investigators propose a double-blinded randomized study evaluating the effectiveness of tranexamic acid in reducing postoperative swelling and haematoma formation after the Latarjet procedure. The purpose of this study is to assess the efficacy of tranexamic acid (TXA), given via intra-articular injection at the time of surgery in patients undergoing the Latarjet procedure for shoulder instability.

Timeline

Start
2018-03-01
Primary completion
2019-03-01
Completion
2019-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 1 g Intravenous

Indications

No indication recorded.